Sugi Predict

Sugi Predict / Compounds / SCHEMBL414201

SCHEMBL414201

SCHEMBL414201

CC(=O)Oc1cccc(C(=O)Cl)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.56
▸ KDM4E B2RXH2 6/20 0.53
▸ HSD17B10 Q99714 5/20 0.53
▸ HPGD P15428 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ PTGS2 P35354 3/20 0.53
▸ BLM P54132 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ ITGB3 P05106 1/20 0.53
▸ ITGA2B P08514 1/20 0.53
▸ HMGB1 P09429 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ GGT1 P19440 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ NAPRT Q6XQN6 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ LMNA P02545 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178884 0.84 KDM4E (0.70) ACHEKDM4EHSD17B10HPGDALDH1A1
SCHEMBL1332285 0.83 PTGS2 (0.69) KDM4EHSD17B10HPGDALDH1A1PTGS2
SCHEMBL30269568 0.83 PTGS2 (0.69) KDM4EHSD17B10HPGDALDH1A1PTGS2
SCHEMBL133699 0.83 PTGS2 (0.69) KDM4EHSD17B10HPGDALDH1A1PTGS2
SCHEMBL544041 0.82 ACHE (0.69) ACHEKDM4EHSD17B10HPGDALDH1A1
SCHEMBL415898 0.82 MAPK1 (0.72) ACHEKDM4EHSD17B10HPGDALDH1A1
Acetone SCHEMBL28889942 0.81 PTGS2 (0.67) KDM4EHSD17B10HPGDALDH1A1PTGS2
SCHEMBL64927 0.81 CTSD (0.49) HTT
SCHEMBL8159114 0.81 ACHE (0.54) ACHEKDM4EHSD17B10HPGDALDH1A1
SCHEMBL5645648 0.79 KDM4E (0.59) ACHEKDM4EHSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116905261-A Preparation method of low-conductivity liquid crystal glass substrate backing paper 浙江凯丰新材料股份有限公司 2023-10-20 — — CN claimed
US-6051732-A REACTING 3-AMINONAPHTHALENE-1,5-DISULFONIC ACID SALT WITH ALKALI METAL HYDROXIDE, REACTING PRODUCT WITH ACETIC ANHYDRIDE, PRECIPITATING 3-ACETOXY-2-METHYLBENZOIC ACID BY ADDITION OF ACID, REACTING IT WITH ACID CHLORIDE CLARIANT GMBH (DE) 2000-04-18 — — US claimed
CN-116905261-A Preparation method of low-conductivity liquid crystal glass substrate backing paper 浙江凯丰新材料股份有限公司 2023-10-20 — — CN disclosed
WO-2022115654-A1 METHODS FOR TREATING SARS-COV-2 INFECTION ACADEMIA SINICA (TW) 2022-06-02 — — WO disclosed
US-10851119-B2 Boron-containing diacylhydrazines INTREXON CORPORATION (US) 2020-12-01 — — US disclosed
US-20200157122-A1 BORON-CONTAINING DIACYLHYDRAZINES INTREXON CORP (US) 2020-05-21 — — US disclosed
US-10464951-B2 Boron-containing diacylhydrazines INTREXON CORPORATION (US) 2019-11-05 — — US disclosed
EP-2970106-B1 BORON-CONTAINING DIACYLHYDRAZINES INTREXON CORP (US) 2018-05-16 — — EP disclosed
US-20180111929-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2018-04-26 — — US disclosed
US-20180079759-A1 Boron-Containing Diacylhydrazines INTREXON CORPORATION (US) 2018-03-22 — — US disclosed
US-20180079759-A1 Boron-Containing Diacylhydrazines INTREXON CORPORATION (US) 2018-03-22 — — US disclosed
US-5962704-A Production of amide derivatives and intermediate compounds therefor JAPAN TOBACCO INC. (JP) 1999-10-05 — — US disclosed
EP-0931071-A1 METHODS OF MAKING HIV-PROTEASE INHIBITORS AND INTERMEDIATES FOR MAKING THEM AGOURON PHARMACEUTICALS, INC. (US) 1999-07-28 — — EP disclosed
US-5925759-A PRODUCING NELFINAVIR MESYLATE FROM TARTARIC ACID AGOURON PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
EP-0927165-A2 INTERMEDIATES FOR MAKING HIV-PROTEASE INHIBITORS AND METHODS OF MAKING HIV-PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1999-07-07 — — EP disclosed
EP-0891964-A1 Process for producing of 3-acetoxy-2-methyl-benzoyl chloride Clariant GmbH (DE) 1999-01-20 — — EP disclosed
WO-1998040357-A2 HIV PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1998-09-17 — — WO disclosed
WO-1998009951-A2 INTERMEDIATES FOR MAKING HIV-PROTEASE INHIBITORS AND METHODS OF MAKING HIV-PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1998-03-12 — — WO disclosed
WO-1998009952-A1 METHODS OF MAKING HIV-PROTEASE INHIBITORS AND INTERMEDIATES FOR MAKING THEM AGOURON PHARMACEUTICALS, INC. (US) 1998-03-12 — — WO disclosed
US-5705647-A BENZOIC ACID OXAZOLE DERIVATIVES FOR TREATMENT OF AIDS AGOURON PHARMACEUTICALS, INC. (US) 1998-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464951-B2 Boron-containing diacylhydrazines CD22, BRDT, BCR ACHE 4101/4885KDM4E 1805/4885HSD17B10 701/4885
US-10851119-B2 Boron-containing diacylhydrazines CD22, BRDT, BCR ACHE 4101/4885KDM4E 1805/4885HSD17B10 701/4885
US-20180111929-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR MAP3K20, MAP3K13, MAP3K8 ACHE 4538/4885KDM4E 2029/4885HSD17B10 2754/4885
US-20200157122-A1 BORON-CONTAINING DIACYLHYDRAZINES CD22, BRDT, BCR ACHE 4101/4885KDM4E 1805/4885HSD17B10 701/4885
US-20180079759-A1 Boron-Containing Diacylhydrazines CD22, BRDT, BCR ACHE 4101/4885KDM4E 1805/4885HSD17B10 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.